InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Congress considers biosimilars

Eileen McDermott, New York

The US House of Representatives is considering a bill that would establish a framework for allowing generic biologics to enter the US market

The Pathway for Biosimilars Act was re-introduced this congressional session by US representatives Anna Eshoo, a Democrat from California, Jay Inslee, a Democrat from Washington and Joe Barton, a Republican from Texas.

Generic biologics, or biosimilars, are products that attempt...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null



May / June 2019

From trademarks to trade secrets: in-house tips on brand protection in China

Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies

Most read articles